Effectiveness of fluvoxamine at preventing COVID-19 infection from turning severe. | Eur Neuropsychopharmacol;67: 83-85, 2023 02. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Effectiveness of fluvoxamine at preventing COVID-19 infection from turning severe.

Boretti, Alberto.

Boretti A; Independent Scientist, Johnsonville Road, Johnsonville, Wellington 6037, New Zealand. Electronic address: a.a.boretti@gmail.com.

Eur Neuropsychopharmacol ; 67: 83-85, 2023 02.

Article in English | MEDLINE | ID: covidwho-2158813

Subject(s)

COVID-19; Fluvoxamine; Humans; Fluvoxamine/therapeutic use; COVID-19 Drug Treatment; Selective Serotonin Reuptake Inhibitors

Keywords

COVID-19; Cytokines; Fluvoxamine; Respiratory disease

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Fluvoxamine / COVID-19 Type of study: Experimental Studies Limits: Humans Language: English Journal: Eur Neuropsychopharmacol Journal subject: Psychopharmacology Year: 2023 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Fluvoxamine / COVID-19 Type of study: Experimental Studies Limits: Humans Language: English Journal: Eur Neuropsychopharmacol Journal subject: Psychopharmacology Year: 2023 Document Type: Article